Ketogenic diets, mitochondria, and neurological diseases

Journal of Lipid Research

Volumn 55, Issue 11, 2014, Pages 2211-2228

  Gano, Lindsey B ^a   Patel, Manisha ^a   Rho, Jong M ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b ALBERTA CHILDREN S HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Cellular signaling; Fatty acids; Ketone; Oxidative stress

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; KETONE BODY; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MEDIUM CHAIN TRIACYLGLYCEROL; SIRTUIN;

ALZHEIMER DISEASE; AUTISM; BRAIN CANCER; CITRIC ACID CYCLE; CLINICAL EFFECTIVENESS; CLINICAL STUDY; DIET THERAPY; DISEASE CONTROL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPILEPSY; GLYCEMIC INDEX; HUMAN; KETOGENESIS; KETOGENIC DIET; LATENT PERIOD; LIPID DIET; METABOLIC REGULATION; MIGRAINE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MODIFIED ATKINS DIET; NERVOUS SYSTEM INFLAMMATION; NERVOUS SYSTEM INJURY; NEUROLOGIC DISEASE; NONHUMAN; PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; ANIMAL; METABOLISM; PATHOLOGY;

ANIMALS; HUMANS; KETOGENIC DIET; KETONE BODIES; MITOCHONDRIA; NERVOUS SYSTEM DISEASES;

EID: 84965191205     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R048975     Document Type: Review

References (183)

1. Vining, E. P., J. M. Freeman, K. Ballaban-Gil, C. S. Camfield, P. R. Camfield, G. L. Holmes, S. Shinnar, R. Shuman, E. Trevathan, and J. W. Wheless. 1998. A multicenter study of the efficacy of the ketogenic diet. Arch. Neurol. 55: 1433-1437.
2. Neal, E. G., H. Chaffe, R. H. Schwartz, M. S. Lawson, N. Edwards, G. Fitzsimmons, A. Whitney, and J. H. Cross. 2008. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 7: 500-506.
3. Stafstrom, C. E., and J. M. Rho. 2012. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front. Pharmacol. 3: 59.
4. Barañano, K. W., and A. L. Hartman. 2008. The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr. Treat. Options Neurol. 10: 410-419.
5. Waldbaum, S., and M. Patel. 2010. Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy? J. Bioenerg. Biomembr. 42: 449-455.
6. Milder, J., and M. Patel. 2012. Modulation of oxidative stress and mitochondrial function by the ketogenic diet. Epilepsy Res. 100: 295-303.
7. Lin, M. T., and M. F. Beal. 2006. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 443: 787-795.
8. Pathak, D., A. Berthet, and K. Nakamura. 2013. Energy failure: does it contribute to neurodegeneration? Ann. Neurol. 74: 506-516.
9. Roth, J., A. L. Szulc, and A. Danoff. 2011. Energy, evolution, and human diseases: an overview. Am. J. Clin. Nutr. 93: 875S-883S.
10. Schiff, M., P. Benit, A. Coulibaly, S. Loublier, R. El-Khoury, and P. Rustin. 2011. Mitochondrial response to controlled nutrition in health and disease. Nutr. Rev. 69: 65-75.
11. McKay, J. A., and J. C. Mathers. 2011. Diet induced epigenetic changes and their implications for health. Acta Physiol. (Oxf.). 202: 103-118.
12. Roopra, A., R. Dingledine, and J. Hsieh. 2012. Epigenetics and epilepsy. Epilepsia. 53(Suppl 9): 2-10.
13. Urdinguio, R. G., J. V. Sanchez-Mut, and M. Esteller. 2009. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 8: 1056-1072.
14. Masino, S. A., and J. M. Rho. 2012. Mechanisms of ketogenic diet action. In Jasper's Basic Mechanisms of the Epilepsies. J. L. Noebels, M. Avoli, M. A. Rogawski, et al., editors. Oxford University Press, Bethesda, MD.
15. Lennox, W. G., and S. Cobb. 1928. Epilepsy: from the standpoint of physiology and treatment. Medicine. 7: 105-290.
16. Bailey, E. E., H. H. Pfeifer, and E. A. Thiele. 2005. The use of diet in the treatment of epilepsy. Epilepsy Behav. 6: 4-8.
17. Wheless, J. W. 2008. History of the ketogenic diet. Epilepsia. 49(Suppl 8): 3-5.
18. Conklin, H. W. 1922. Cause and treatment of epilepsy. J. Am. Osteopath. Assoc. 26: 11-14.
19. Guelpa, G., and A. Marie. 1911. La lutte contre l'epilepsie par la desintoxication et par la reeducation alimentaire. Revue de Therapie Medico-Chirurgicale. 78: 8-13.
20. Geyelin, H. R. 1921. Fasting as a method for treating epilepsy. Med. Rec. 99: 1037-1039.
21. Lennox, W. G., and S. Cobb. 1928. Studies in epilepsy: VIII. The clinical effects of fasting. Arch. Neurol. Psychiatry. 20: 771-779.
22. Woodyatt, R. T. 1921. Objects and method of diet adjustment in diabetics. Arch. Intern. Med. 28: 125-141.
23. Wilder, R. M. 1921. The effect of ketonemia on the course of epilepsy. Mayo Clinic Bulletin. 2: 307.
24. Wilder, R. M. 1922. The threshold of ketogenesis. J. Biol. Chem. 52: 393-401.
25. Peterman, M. G. 1925. The ketogenic diet in epilepsy. J. Am. Med. Assoc. 84: 1979-1983.
26. Peterman, M. G. 1924. The ketogenic diet in the treatment of epilepsy: a preliminary report. Am. J. Dis. Child. 28: 28-33.
27. Huttenlocher, P. R., A. J. Wilbourn, and J. M. Signore. 1971. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. 21: 1097-1103.
28. Neal, E. G., H. Chaffe, R. H. Schwartz, M. S. Lawson, N. Edwards, G. Fitzsimmons, A. Whitney, and J. H. Cross. 2009. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 50: 1109-1117.
29. Muzykewicz, D. A., D. A. Lyczkowski, N. Memon, K. D. Conant, H. H. Pfeifer, and E. A. Thiele. 2009. Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia. 50: 1118-1126.
30. Kossoff, E. H., M. C. Cervenka, B. J. Henry, C. A. Haney, and Z. Turner. 2013. A decade of the modified Atkins diet (2003-2013): Results, insights, and future directions. Epilepsy Behav. 29: 437-442.
31. Lutas, A., and G. Yellen. 2013. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 36: 32-40.
32. Kossoff, E. H., and J. M. Rho. 2009. Ketogenic diets: evidence for short- and long-term efficacy. Neurotherapeutics. 6: 406-414.
33. Kossoff, E. H., B. A. Zupec-Kania, and J. M. Rho. 2009. Ketogenic diets: an update for child neurologists. J. Child Neurol. 24: 979-988.
34. Kossoff, E. H., B. A. Zupec-Kania, P. E. Amark, K. R. Ballaban-Gil, A. G. Christina Bergqvist, R. Blackford, J. R. Buchhalter, R. H. Caraballo, J. Helen Cross, M. G. Dahlin, et al. 2009. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 50: 304-317.
35. Freeman, J. M., E. H. Kossoff, and A. L. Hartman. 2007. The ketogenic diet: one decade later. Pediatrics. 119: 535-543.
36. Bergqvist, A. G., J. I. Schall, P. R. Gallagher, A. Cnaan, and V. A. Stallings. 2005. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia. 46: 1810-1819.
37. Kossoff, E. H., L. C. Laux, R. Blackford, P. F. Morrison, P. L. Pyzik, R. M. Hamdy, Z. Turner, and D. R. Nordli, Jr. 2008. When do seizures usually improve with the ketogenic diet? Epilepsia. 49: 329-333.
38. Freeman, J. M., and E. P. Vining. 1999. Seizures decrease rapidly after fasting: preliminary studies of the ketogenic diet. Arch. Pediatr. Adolesc. Med. 153: 946-949.
39. Bough, K. J., and J. M. Rho. 2007. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 48: 43-58.
40. Huttenlocher, P. R. 1976. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr. Res. 10: 536-540.
41. Pierre, K., and L. Pellerin. 2005. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J. Neurochem. 94: 1-14.
42. Prins, M. L. 2008. Cerebral metabolic adaptation and ketone metabolism after brain injury. J. Cereb. Blood Flow Metab. 28: 1-16.
43. Mady, M. A., E. H. Kossoff, A. L. McGregor, J. W. Wheless, P. L. Pyzik, and J. M. Freeman. 2003. The ketogenic diet: adolescents can do it, too. Epilepsia. 44: 847-851.
44. Klein, P., J. Janousek, A. Barber, and R. Weissberger. 2010. Ketogenic diet treatment in adults with refractory epilepsy. Epilepsy Behav. 19: 575-579.
45. Payne, N. E., J. H. Cross, J. W. Sander, and S. M. Sisodiya. 2011. The ketogenic and related diets in adolescents and adults - a review. Epilepsia. 52: 1941-1948.
46. Kwiterovich, P. O., Jr., E. P. Vining, P. Pyzik, R. Skolasky, Jr., and J. M. Freeman. 2003. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA. 290: 912-920.
47. Groesbeck, D. K., R. M. Bluml, and E. H. Kossoff. 2006. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev. Med. Child Neurol. 48: 978-981.
48. Bough, K. J., J. Wetherington, B. Hassel, J. F. Pare, J. W. Gawryluk, J. G. Greene, R. Shaw, Y. Smith, J. D. Geiger, and R. J. Dingledine. 2006. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 60: 223-235.
49. Hartman, A. L., M. Lyle, M. A. Rogawski, and M. Gasior. 2008. Efficacy of the ketogenic diet in the 6-Hz seizure test. Epilepsia. 49: 334-339.
50. Rho, J. M., D. W. Kim, C. A. Robbins, G. D. Anderson, and P. A. Schwartzkroin. 1999. Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Res. 37: 233-240.
51. D'Agostino, D. P., R. Pilla, H. E. Held, C. S. Landon, M. Puchowicz, H. Brunengraber, C. Ari, P. Arnold, and J. B. Dean. 2013. Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304: R829-R836.
52. Hori, A., P. Tandon, G. L. Holmes, and C. E. Stafstrom. 1997. Ketogenic diet: effects on expression of kindled seizures and behavior in adult rats. Epilepsia. 38: 750-758.
53. Xu, X. P., R. P. Sun, and R. F. Jin. 2006. Effect of ketogenic diet on hippocampus mossy fiber sprouting and GluR5 expression in kainic acid induced rat model. Chin. Med. J. (Engl.). 119: 1925-1929.
54. Su, S. W., M. R. Cilio, Y. Sogawa, D. C. Silveira, G. L. Holmes, and C. E. Stafstrom. 2000. Timing of ketogenic diet initiation in an experimental epilepsy model. Brain Res. Dev. Brain Res. 125: 131-138.
55. Erratum. Su, S. W., M. R. Cilio, Y. Sogawa, D. C. Silveira, G. L. Holmes, and C. E. Stafstrom. Timing of ketogenic diet initiation in an experimental epilepsy model. 2001. Brain Res. Dev. Brain Res. 128: 197.
56. Kossoff, E. H., H. Rowley, S. R. Sinha, and E. P. Vining. 2008. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia. 49: 316-319.
57. Kossoff, E. H., and J. L. Dorward. 2008. The modified Atkins diet. Epilepsia. 49(Suppl 8): 37-41.
58. Cross, J. H., and E. G. Neal. 2008. The ketogenic diet-update on recent clinical trials. Epilepsia. 49(Suppl 8): 6-10.
59. Bishop, N. A., and L. Guarente. 2007. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat. Rev. Genet. 8: 835-844.
60. Fusco, S., and G. Pani. 2013. Brain response to calorie restriction. Cell. Mol. Life Sci. 70: 3157-3170.
61. Libert, S., and L. Guarente. 2013. Metabolic and neuropsychiatric effects of calorie restriction and sirtuins. Annu. Rev. Physiol. 75: 669-684.
62. Kossoff, E. H., G. L. Krauss, J. R. McGrogan, and J. M. Freeman. 2003. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 61: 1789-1791.
63. Kossoff, E. H., J. R. McGrogan, R. M. Bluml, D. J. Pillas, J. E. Rubenstein, and E. P. Vining. 2006. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia. 47: 421-424.
64. Greene, A. E., M. T. Todorova, R. McGowan, and T. N. Seyfried. 2001. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia. 42: 1371-1378.
65. Pfeifer, H. H., D. A. Lyczkowski, and E. A. Thiele. 2008. Low glycemic index treatment: implementation and new insights into efficacy. Epilepsia. 49(Suppl 8): 42-45.
66. Pfeifer, H. H., and E. A. Thiele. 2005. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology. 65: 1810-1812.
67. Guarente, L. 2013. Calorie restriction and sirtuins revisited. Genes Dev. 27: 2072-2085.
68. Hartman, A. L., and C. E. Stafstrom. 2013. Harnessing the power of metabolism for seizure prevention: focus on dietary treatments. Epilepsy Behav. 26: 266-272.
69. Bough, K. J., R. Valiyil, F. T. Han, and D. A. Eagles. 1999. Seizure resistance is dependent upon age and calorie restriction in rats fed a ketogenic diet. Epilepsy Res. 35: 21-28.
70. Todorova, M. T., P. Tandon, R. A. Madore, C. E. Stafstrom, and T. N. Seyfried. 2000. The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia. 41: 933-940.
71. Mantis, J. G., N. A. Centeno, M. T. Todorova, R. McGowan, and T. N. Seyfried. 2004. Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr. Metab. (Lond). 1: 11.
72. Greene, A. E., M. T. Todorova, and T. N. Seyfried. 2003. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J. Neurochem. 86: 529-537.
73. Veech, R. L., B. Chance, Y. Kashiwaya, H. A. Lardy, and G. F. Cahill, Jr. 2001. Ketone bodies, potential therapeutic uses. IUBMB Life. 51: 241-247.
74. Cotter, D. G., R. C. Schugar, and P. A. Crawford. 2013. Ketone body metabolism and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 304: H1060-H1076.
75. Keith, H. M. 1933. Factors influencing experimentally produced convulsions. Arch. Neurol. Psychiatry. 29: 148-154.
76. Rho, J. M., G. D. Anderson, S. D. Donevan, and H. S. White. 2002. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia. 43: 358-361.
77. Likhodii, S. S., I. Serbanescu, M. A. Cortez, P. Murphy, O. C. Snead III, and W. M. Burnham. 2003. Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann. Neurol. 54: 219-226.
78. Yudkoff, M., Y. Daikhin, I. Nissim, O. Horyn, A. Lazarow, B. Luhovyy, and S. Wehrli. 2005. Response of brain amino acid metabolism to ketosis. Neurochem. Int. 47: 119-128.
79. Dahlin, M., A. Elfving, U. Ungerstedt, and P. Amark. 2005. The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res. 64: 115-125.
80. Melø, T. M., A. Nehlig, and U. Sonnewald. 2006. Neuronalglial interactions in rats fed a ketogenic diet. Neurochem. Int. 48: 498-507.
81. Cheng, C. M., K. Hicks, J. Wang, D. A. Eagles, and C. A. Bondy. 2004. Caloric restriction augments brain glutamic acid decarboxylase-65 and -67 expression. J. Neurosci. Res. 77: 270-276.
82. Bough, K. J., M. Paquet, J. F. Pare, B. Hassel, Y. Smith, R. A. Hall, and R. Dingledine. 2007. Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic diet. Epilepsy Res. 74: 232-236.
83. Juge, N., J. A. Gray, H. Omote, T. Miyaji, T. Inoue, C. Hara, H. Uneyama, R. H. Edwards, R. A. Nicoll, and Y. Moriyama. 2010. Metabolic control of vesicular glutamate transport and release. Neuron. 68: 99-112.
84. Thio, L. L., M. Wong, and K. A. Yamada. 2000. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology. 54: 325-331.
85. Ma, W., J. Berg, and G. Yellen. 2007. Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels. J. Neurosci. 27: 3618-3625.
86. Tanner, G. R., A. Lutas, J. R. Martinez-Francois, and G. Yellen. 2011. Single K ATP channel opening in response to action potential firing in mouse dentate granule neurons. J. Neurosci. 31: 8689-8696.
87. Won, Y. J., V. B. Lu, H. L. Puhl III, and S. R. Ikeda. 2013. β-Hydroxybutyrate modulates N-type calcium channels in rat sympathetic neurons by acting as an agonist for the G-protein-coupled receptor FFA3. J. Neurosci. 33: 19314-19325.
88. Giménez-Cassina, A., J. R. Martínez-Francois, J. K. Fisher, B. Szlyk, K. Polak, J. Wiwczar, G. R. Tanner, A. Lutas, G. Yellen, and N. N. Danial. 2012. BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures. Neuron. 74: 719-730.
89. DeVivo, D. C., M. P. Leckie, J. S. Ferrendelli, and D. B. McDougal, Jr. 1978. Chronic ketosis and cerebral metabolism. Ann. Neurol. 3: 331-337.
90. Kim do, Y., J. Vallejo, and J. M. Rho. 2010. Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. J. Neurochem. 114: 130-141.
91. Masino, S. A., M. Kawamura, Jr., D. N. Ruskin, J. D. Geiger, and D. Boison. 2012. Purines and neuronal excitability: links to the ketogenic diet. Epilepsy Res. 100: 229-238.
92. Pascual, O., K. B. Casper, C. Kubera, J. Zhang, R. Revilla-Sanchez, J. Y. Sul, H. Takano, S. J. Moss, K. McCarthy, and P. G. Haydon. 2005. Astrocytic purinergic signaling coordinates synaptic networks. Science. 310: 113-116.
93. Masino, S. A., T. Li, P. Theofilas, U. S. Sandau, D. N. Ruskin, B. B. Fredholm, J. D. Geiger, E. Aronica, and D. Boison. 2011. A ketogenic diet suppresses seizures in mice through adenosine A(1) receptors. J. Clin. Invest. 121: 2679-2683.
94. Rowley, S., and M. Patel. 2013. Mitochondrial involvement and oxidative stress in temporal lobe epilepsy. Free Radic. Biol. Med. 62: 121-131.
95. Veech, R. L. 2004. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot. Essent. Fatty Acids. 70: 309-319.
96. Ziegler, D. R., L. C. Ribeiro, M. Hagenn, I. R. Siqueira, E. Araujo, I. L. Torres, C. Gottfried, C. A. Netto, and C. A. Goncalves. 2003. Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochem. Res. 28: 1793-1797.
97. Jarrett, S. G., J. B. Milder, L. P. Liang, and M. Patel. 2008. The ketogenic diet increases mitochondrial glutathione levels. J. Neurochem. 106: 1044-1051.
98. Milder, J. B., L. P. Liang, and M. Patel. 2010. Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol. Dis. 40: 238-244.
99. Suzuki, T., H. Motohashi, and M. Yamamoto. 2013. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol. Sci. 34: 340-346.
100. Sekhar, K. R., G. Rachakonda, and M. L. Freeman. 2010. Cysteine-based regulation of the CUL3 adaptor protein Keap1. Toxicol. Appl. Pharmacol. 244: 21-26.
101. Mazzuferi, M., G. Kumar, J. van Eyll, B. Danis, P. Foerch, and R. M. Kaminski. 2013. Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy. Ann. Neurol. 74: 560-568.
102. Maalouf, M., and J. M. Rho. 2008. Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies. J. Neurosci. Res. 86: 3322-3330.
103. Maalouf, M., P. G. Sullivan, L. Davis, D. Y. Kim, and J. M. Rho. 2007. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience. 145: 256-264.
104. Kim do, Y., L. M. Davis, P. G. Sullivan, M. Maalouf, T. A. Simeone, J. van Brederode, and J. M. Rho. 2007. Ketone bodies are protective against oxidative stress in neocortical neurons. J. Neurochem. 101: 1316-1326.
105. Sullivan, P. G., C. Dube, K. Dorenbos, O. Steward, and T. Z. Baram. 2003. Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann. Neurol. 53: 711-717.
106. Azzu, V., and M. D. Brand. 2010. The on-off switches of the mitochondrial uncoupling proteins. Trends Biochem. Sci. 35: 298-307.
107. Sullivan, P. G., N. A. Rippy, K. Dorenbos, R. C. Concepcion, A. K. Agarwal, and J. M. Rho. 2004. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 55: 576-580.
108. Shimazu, T., M. D. Hirschey, J. Newman, W. He, K. Shirakawa, N. Le Moan, C. A. Grueter, H. Lim, L. R. Saunders, R. D. Stevens, et al. 2013. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 339: 211-214.
109. Kovac, S., A. M. Domijan, M. C. Walker, and A. Y. Abramov. 2012. Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death. J. Cell Sci. 125: 1796-1806.
110. Stafstrom, C. E., J. C. Ockuly, L. Murphree, M. T. Valley, A. Roopra, and T. P. Sutula. 2009. Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models. Ann. Neurol. 65: 435-447.
111. Garriga-Canut, M., B. Schoenike, R. Qazi, K. Bergendahl, T. J. Daley, R. M. Pfender, J. F. Morrison, J. Ockuly, C. Stafstrom, T. Sutula, A. Roopra. 2006. 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 9: 1382-1387.
112. Wellen, K. E., G. Hatzivassiliou, U. M. Sachdeva, T. V. Bui, J. R. Cross, and C. B. Thompson. 2009. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 324: 1076-1080.
113. Albaugh, B. N., K. M. Arnold, and J. M. Denu. 2011. KAT(ching) metabolism by the tail: insight into the links between lysine acetyltransferases and metabolism. ChemBioChem. 12: 290-298.
114. Hebert, A. S., K. E. Dittenhafer-Reed, W. Yu, D. J. Bailey, E. S. Selen, M. D. Boersma, J. J. Carson, M. Tonelli, A. J. Balloon, A. J. Higbee, et al. 2013. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell. 49: 186-199.
115. Wagner, G. R., and R. M. Payne. 2013. Widespread and enzyme-independent Nε-acetylation and Nε-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J. Biol. Chem. 288: 29036-29045.
116. Lian, X. Y., F. A. Khan, and J. L. Stringer. 2007. Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J. Neurosci. 27: 12007-12011.
117. Fraser, D. D., S. Whiting, R. D. Andrew, E. A. Macdonald, K. Musa-Veloso, and S. C. Cunnane. 2003. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology. 60: 1026-1029.
118. Michael-Titus, A. T., and J. V. Priestley. 2014. Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity? Trends Neurosci. 37: 30-38.
119. Schlanger, S., M. Shinitzky, and D. Yam. 2002. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia. 43: 103-104.
120. Yuen, A. W., J. W. Sander, D. Fluegel, P. N. Patsalos, G. S. Bell, T. Johnson, and M. J. Koepp. 2005. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav. 7: 253-258.
121. Bromfield, E., B. Dworetzky, S. Hurwitz, Z. Eluri, L. Lane, S. Replansky, and D. Mostofsky. 2008. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav. 12: 187-190.
122. Taha, A. Y., M. A. Ryan, and S. C. Cunnane. 2005. Despite transient ketosis, the classic high-fat ketogenic diet induces marked changes in fatty acid metabolism in rats. Metabolism. 54: 1127-1132.
123. Cullingford, T. E., D. A. Eagles, and H. Sato. 2002. The ketogenic diet upregulates expression of the gene encoding the key ketogenic enzyme mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in rat brain. Epilepsy Res. 49: 99-107.
124. Taha, A. Y., W. M. Burnham, and S. Auvin. 2010. Polyunsaturated fatty acids and epilepsy. Epilepsia. 51: 1348-1358.
125. Suzuki, M., K. Sato, S. Dohi, T. Sato, A. Matsuura, and A. Hiraide. 2001. Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn. J. Pharmacol. 87: 143-150.
126. Noh, H. S., H. P. Lee, D. W. Kim, S. S. Kang, G. J. Cho, J. M. Rho, and W. S. Choi. 2004. A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Brain Res. Mol. Brain Res. 129: 80-87.
127. Tieu, K., C. Perier, C. Caspersen, P. Teismann, D. C. Wu, S. D. Yan, A. Naini, M. Vila, V. Jackson-Lewis, R. Ramasamy, et al. 2003. D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Invest. 112: 892-901.
128. Willis, S., J. Stoll, L. Sweetman, and K. Borges. 2010. Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. Neurobiol. Dis. 40: 565-572.
129. Hadera, M. G., O. B. Smeland, T. S. McDonald, K. N. Tan, U. Sonnewald, and K. Borges. 2014. Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy. J. Neurochem. 129: 107-119.
130. Kovac, S., A. Y. Abramov, and M. C. Walker. 2013. Energy depletion in seizures: anaplerosis as a strategy for future therapies. Neuropharmacology. 69: 96-104.
131. Mattson, M. P. 2012. Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab. 16: 706-722.
132. Sampath, H., and J. M. Ntambi. 2005. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu. Rev. Nutr. 25: 317-340.
133. Porta, N., L. Vallee, C. Lecointe, E. Bouchaert, B. Staels, R. Bordet, and S. Auvin. 2009. Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, exerts anticonvulsive properties. Epilepsia. 50: 943-948.
134. Maurois, P., S. Rocchi, N. Pages, P. Bac, J. P. Stables, P. Gressens, and J. Vamecq. 2008. The PPARgamma agonist FMOC-L-leucine protects both mature and immature brain. Biomed. Pharmacother. 62: 259-263.
135. Yu, X., X. G. Shao, H. Sun, Y. N. Li, J. Yang, Y. C. Deng, and Y. G. Huang. 2008. Activation of cerebral peroxisome proliferator-activated receptors gamma exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus. Brain Res. 1200: 146-158.
136. Cullingford, T. E., C. T. Dolphin, and H. Sato. 2002. The peroxisome proliferator-activated receptor alpha-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain. Neuropharmacology. 42: 724-730.
137. Hardie, D. G., and K. Sakamoto. 2006. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda). 21: 48-60.
138. Kennedy, A. R., P. Pissios, H. Otu, R. Roberson, B. Xue, K. Asakura, N. Furukawa, F. E. Marino, F. F. Liu, B. B. Kahn, et al. 2007. A high-fat, ketogenic diet induces a unique metabolic state in mice. Am. J. Physiol. Endocrinol. Metab. 292: E1724-E1739.
139. Erratum. Kennedy, A. R., P. Pissios, H. Otu, R. Roberson, B. Xue, K. Asakura, N. Furukawa, F. E. Marino, F. F. Liu, B. B. Kahn, et al. A high-fat, ketogenic diet induces a unique metabolic state in mice. 2009. Am. J. Physiol. Endocrinol. Metab. 296: E1179.
140. McDaniel, S. S., N. R. Rensing, L. L. Thio, K. A. Yamada, and M. Wong. 2011. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia. 52: e7-e11.
141. Johnson, S. C., P. S. Rabinovitch, and M. Kaeberlein. 2013. mTOR is a key modulator of ageing and age-related disease. Nature. 493: 338-345.
142. Wong, M. 2013. Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed. J. 36: 40-50.
143. Houtkooper, R. H., R. W. Williams, and J. Auwerx. 2010. Metabolic networks of longevity. Cell. 142: 9-14.
144. Houtkooper, R. H., E. Pirinen, and J. Auwerx. 2012. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13: 225-238.
145. Srivastava, S., U. Baxa, G. Niu, X. Chen, and R. L. Veech. 2013. A ketogenic diet increases brown adipose tissue mitochondrial proteins and UCP1 levels in mice. IUBMB Life. 65: 58-66.
146. Rardin, M. J., J. C. Newman, J. M. Held, M. P. Cusack, D. J. Sorensen, B. Li, B. Schilling, S. D. Mooney, C. R. Kahn, E. Verdin, et al. 2013. Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways. Proc. Natl. Acad. Sci. USA. 110: 6601-6606.
147. Rardin, M. J., W. He, Y. Nishida, J. C. Newman, C. Carrico, S. R. Danielson, A. Guo, P. Gut, A. K. Sahu, B. Li, et al. 2013. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 18: 920-933.
148. Shimazu, T., M. D. Hirschey, L. Hua, K. E. Dittenhafer-Reed, B. Schwer, D. B. Lombard, Y. Li, J. Bunkenborg, F. W. Alt, J. M. Denu, et al. 2010. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 12: 654-661.
149. de Castro, I. P., L. M. Martins, and R. Tufi. 2010. Mitochondrial quality control and neurological disease: an emerging connection. Expert Rev. Mol. Med. 12: e12.
150. Calì, T., D. Ottolini, and M. Brini. 2012. Mitochondrial Ca(2+) and neurodegeneration. Cell Calcium. 52: 73-85.
151. Johri, A., and M. F. Beal. 2012. Mitochondrial dysfunction in neurodegenerative diseases. J. Pharmacol. Exp. Ther. 342: 619-630.
152. Palop, J. J., and L. Mucke. 2009. Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol. 66: 435-440.
153. Reger, M. A., S. T. Henderson, C. Hale, B. Cholerton, L. D. Baker, G. S. Watson, K. Hyde, D. Chapman, and S. Craft. 2004. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol. Aging. 25: 311-314.
154. Krikorian, R., M. D. Shidler, K. Dangelo, S. C. Couch, S. C. Benoit, and D. J. Clegg. 2012. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol. Aging. 33: 425.e19-425.e27.
155. Henderson, S. T., J. L. Vogel, L. J. Barr, F. Garvin, J. J. Jones, and L. C. Costantini. 2009. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr. Metab. (Lond). 6: 31.
156. Van der Auwera, I., S. Wera, F. Van Leuven, and S. T. Henderson. 2005. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr. Metab. (Lond). 2: 28.
157. Kashiwaya, Y., T. Takeshima, N. Mori, K. Nakashima, K. Clarke, and R. L. Veech. 2000. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc. Natl. Acad. Sci. USA. 97: 5440-5444.
158. Kashiwaya, Y., C. Bergman, J. H. Lee, R. Wan, M. T. King, M. R. Mughal, E. Okun, K. Clarke, M. P. Mattson, and R. L. Veech. 2013. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol. Aging. 34: 1530-1539.
159. Vanitallie, T. B., C. Nonas, A. Di Rocco, K. Boyar, K. Hyams, and S. B. Heymsfield. 2005. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology. 64: 728-730.
160. de Lau, L. M., M. Bornebroek, J. C. Witteman, A. Hofman, P. J. Koudstaal, and M. M. Breteler. 2005. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology. 64: 2040-2045.
161. Seyfried, T. N., and L. M. Shelton. 2010. Cancer as a metabolic disease. Nutr. Metab. (Lond). 7: 7.
162. Warburg, O. 1956. On the origin of cancer cells. Science. 123: 309-314.
163. Seyfried, T. N., M. A. Kiebish, J. Marsh, L. M. Shelton, L. C. Huysentruyt, and P. Mukherjee. 2011. Metabolic management of brain cancer. Biochim. Biophys. Acta. 1807: 577-594.
164. Seyfried, T. N., T. M. Sanderson, M. M. El-Abbadi, R. McGowan, and P. Mukherjee. 2003. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br. J. Cancer. 89: 1375-1382.
165. Stafford, P., M. G. Abdelwahab, Y. Kim do, M. C. Preul, J. M. Rho, and A. C. Scheck. 2010. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr. Metab. (Lond). 7: 74.
166. Abdelwahab, M. G., K. E. Fenton, M. C. Preul, J. M. Rho, A. Lynch, P. Stafford, and A. C. Scheck. 2012. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS ONE. 7: e36197.
167. Chang, H. T., L. K. Olson, and K. A. Schwartz. 2013. Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy. Nutr. Metab. (Lond). 10: 47.
168. Babikian, T., M. L. Prins, Y. Cai, G. Barkhoudarian, I. Hartonian, D. A. Hovda, and C. C. Giza. 2010. Molecular and physiological responses to juvenile traumatic brain injury: focus on growth and metabolism. Dev. Neurosci. 32: 431-441.
169. Algattas, H., and J. H. Huang. 2014. Traumatic brain injury pathophysiology and treatments: early, intermediate, and late phases post-injury. Int. J. Mol. Sci. 15: 309-341.
170. Prins, M. L., L. S. Fujima, and D. A. Hovda. 2005. Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. J. Neurosci. Res. 82: 413-420.
171. Prins, M. L., S. M. Lee, L. S. Fujima, and D. A. Hovda. 2004. Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats. J. Neurochem. 90: 666-672.
172. Hu, Z. G., H. D. Wang, L. Qiao, W. Yan, Q. F. Tan, and H. X. Yin. 2009. The protective effect of the ketogenic diet on traumatic brain injury-induced cell death in juvenile rats. Brain Inj. 23: 459-465.
173. Yamada, K. A., N. Rensing, and L. L. Thio. 2005. Ketogenic diet reduces hypoglycemia-induced neuronal death in young rats. Neurosci. Lett. 385: 210-214.
174. Davis, L. M., J. R. Pauly, R. D. Readnower, J. M. Rho, and P. G. Sullivan. 2008. Fasting is neuroprotective following traumatic brain injury. J. Neurosci. Res. 86: 1812-1822.
175. Rothstein, J. D. 2009. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65(Suppl 1): S3-S9.
176. Zhao, Z., D. J. Lange, A. Voustianiouk, D. MacGrogan, L. Ho, J. Suh, N. Humala, M. Thiyagarajan, J. Wang, and G. M. Pasinetti. 2006. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 7: 29.
177. Bialer, M. 2012. Why are antiepileptic drugs used for nonepileptic conditions? Epilepsia. 53(Suppl 7): 26-33.
178. Ruskin, D. N., M. Kawamura, and S. A. Masino. 2009. Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS ONE. 4: e8349.
179. Masino, S. A., and D. N. Ruskin. 2013. Ketogenic diets and pain. J. Child Neurol. 28: 993-1001.
180. Ruskin, D. N., J. Svedova, J. L. Cote, U. Sandau, J. M. Rho, M. Kawamura, Jr., D. Boison, and S. A. Masino. 2013. Ketogenic diet improves core symptoms of autism in BTBR mice. PLoS ONE. 8: e65021.
181. Kossoff, E. H., J. Huffman, Z. Turner, and J. Gladstein. 2010. Use of the modified Atkins diet for adolescents with chronic daily headache. Cephalalgia. 30: 1014-1016.
182. Kim do, Y., and J. M. Rho. 2008. The ketogenic diet and epilepsy. Curr. Opin. Clin. Nutr. Metab. Care. 11: 113-120.
183. Waldbaum, S., and M. Patel. 2010. Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res. 88: 23-45.